Back to the search results

Vivantes Klinikum Neukölln

Rudower Straße 48
12351 Berlin

Phone: 030-130-10
Fax: 030-13014-3278
Mail: ed.setnaviv@ofni

http://www.vivantes.de/knk
  • Number of beds: 1.375
  • Number of specialist departments: 25
  • Number of inpatient cases: 35.448
  • Number of partial inpatient cases: 1.082
  • Number of outpatient cases: 82.576
  • Number of cases of inpatient-equivalent psychiatric treatment (StäB): 137
  • Hospital owners: Vivantes - Netzwerk für Gesundheit GmbH (Eigentümer: Land Berlin)
  • Type of provider: öffentlich
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Chronische obstruktive Lungenerkrankung (COPD)

Versorgung im MVZ Adlershof

Quantity performed 32
Exception? No exception
Quantity performed 30
Exception? No exception
Quantity performed 41
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 32
Quantity forecast year: 38
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 30
Quantity forecast year: 35
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 41
Quantity forecast year: 49
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 183
Quantity forecast year: 169
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ26 Decision on measures for quality assurance of targeted lung denervation by catheter ablation in chronic obstructive pulmonary disease
CQ27 Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
283 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
168 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
133 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • https://www.vivantes.de/klinikum-neukoelln/kinderschutzambulanz
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

nur an Phase-II-Studien

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

seit April 2022

Comment

seit April 2021, seit 2023 neue Bundesgesetzgebung in Umsetzung

Comment

ab 2022, neue Bundesgesetzgebung umgesetzt

Comment

seit Oktober 2022

Comment

seit Oktober 2021, Studium mit der Universität der Charité Berlin

Comment

seit Februar 2023, neue Bundesgesetzgebung umgesetzt

Comment

ab 2022, Bundesgesetzgebung umgesetzt

Comment

seit Oktober 2021

Comment

seit 2020, Pflegefachassistenz seit November 2022, Umsetzung der neuen Ausbildung nach Landesgesetzgebung

Comment

Kooperationspartner für die ASH

Eveline Heidenreich

Patientenfürsprecherin Psychiatrie

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-3413
Mail: ed.nilreb@2-knk.viv-ftap

Kathrin Schuhmann

Patientenfürsprecherin Somatik

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-3105
Mail: ed.nilreb@1-knk.viv-ftap

J. Bauerfeld | P. Sperling

Qualitätsmanager*innen

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2483
Mail: ed.setnaviv@knk.mq

C. Mixa | P. Sperling

Qualitätsmanagement

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2483
Mail: ed.setnaviv@knk.mq

Dr. J. Danckert

GF Klinikmanagement

Rudower Straße 48
12351 Berlin

Phone: 030 -130-10
Mail: ed.setnaviv@ofni

Prof. Dr. Reinhold A. Laun

Ärztlicher Direktor

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2121
Mail: ed.setnaviv@nual.dlohnier

PD Dr. Mario Müller

Ärztlicher Direktor

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2061
Mail: ed.setnaviv@relleum.oiram

Dr. Ulrike Zuther

Leitung Vivantes Apotheke Süd

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2560
Mail: ed.setnaviv@rehtuz.ekirlu

Ariane Schulze

Leitung Sozialdienst-Somatik

Rudower Straße 48
12351 Berlin

Phone: 030 -13019-2580
Mail: ed.setnaviv@ezluhcs.enaira

Rudower Straße 48
12351 Berlin

Phone: 030-130-10
Fax: 030-13014-3278
Mail: ed.setnaviv@ofni

Peggy Dubois

Pflegedirektorin

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2350
Mail: ed.setnaviv@siobud.yggep

Detlev Corsepius

Geschäftsführender Direktor

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2100
Mail: ed.setnaviv@knk.dg-tairaterkes

Thomas Wüstner

Geschäftsführender Direktor ab 01.01.2022

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2100
Mail: ed.setnaviv@knk.dg-tairaterkes

K. Runck

Abteilungsleitung Patientensicherheit und Qualität

Rudower Straße 48
12351 Berlin

Phone: 030 -13011-1405
Mail: ed.setnaviv@tnemeganamsteatilauq

Prof. Dr. Reinhold-Alexander Laun

Ärztlicher Direktor

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2121
Mail: ed.setnaviv@nual.adlohnier

PD Dr. med. Mario Müller

Ärztlicher Direktor ab 01.01.2022

Rudower Straße 48
12351 Berlin

Phone: 030 -13014-2061
Mail: ed.setnaviv@relleum.oiram

Yes

IK: 261101878

Location number: 773183000

Old location number: 773183000

Hospital portrait for download